Literature DB >> 24114669

Outcome with immediate direct anastomosis of recurrent laryngeal nerves injured during thyroidectomy.

Jong W Hong1, Tai S Roh, Han-Su Yoo, Hyun J Hong, Hong-Shik Choi, Hang S Chang, Cheong S Park, Young S Kim.   

Abstract

OBJECTIVES/HYPOTHESIS: Management of unrecognized recurrent laryngeal nerve injury typically entails delayed phonosurgical intervention and laryngeal reinnervation, but in cases of recognized injury, nerve anastomosis has been considered standard management. However, the well-organized outcome analysis of nerve anastomosis has been insufficient. We performed immediate direct anastomosis of recurrent laryngeal nerves injured during surgery for thyroid cancer, and subsequent patient outcomes were analyzed. STUDY
DESIGN: A total 14 patients sustaining recurrent laryngeal nerve injury during thyroidectomy were recruited for the study. Patients undergoing immediate direct reparative anastomosis of the injured nerves constituted the test group, whereas the controls of group 2 (n = 4) did not.
METHODS: At follow-up, all patients submitted to rigid laryngoscopy at 3, 6, and 12 months postoperatively. Subjective and objective outcomes of the two groups were then compared.
RESULTS: At 12 months postoperatively, group 1 showed greater improvement in maximum phonation time, glottic gap scores, GRBAS (grade, roughness, breathiness, asthenia, and strain) scales, aspiration scoring, and Voice Handicap Index than controls of group 2. Moreover, group 1 showed an improvement in all five categories at 12 months postoperatively, compared with status at 3 months. None of the patients in group 1 showed laryngoscopic evidence of vocal cord atrophy.
CONCLUSION: In this study, patients undergoing immediate direct recurrent laryngeal nerve anastomosis demonstrated better phonation and perceptually rated voice quality than those who did not undergo repair. LEVEL OF EVIDENCE: 3b.
© 2013 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Injured recurrent laryngeal nerve; direct nerve anastomosis; immediate nerve anastomosis

Mesh:

Year:  2013        PMID: 24114669     DOI: 10.1002/lary.24450

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  Diagnostic, therapeutic and health-care management protocol in thyroid surgery: a position statement of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB).

Authors:  L Rosato; C De Crea; R Bellantone; M L Brandi; G De Toma; S Filetti; P Miccoli; F Pacini; M R Pelizzo; A Pontecorvi; N Avenia; L De Pasquale; M G Chiofalo; A Gurrado; N Innaro; G La Valle; C P Lombardi; P L Marini; G Mondini; B Mullineris; L Pezzullo; M Raffaelli; M Testini; M De Palma
Journal:  J Endocrinol Invest       Date:  2016-04-08       Impact factor: 4.256

Review 2.  Speech therapy after thyroidectomy.

Authors:  Wing-Hei Viola Yu; Che-Wei Wu
Journal:  Gland Surg       Date:  2017-10

Review 3.  Narrative review of management of thyroid surgery complications.

Authors:  Shan Jin; Iwao Sugitani
Journal:  Gland Surg       Date:  2021-03

Review 4.  A narrative review of current therapies in unilateral recurrent laryngeal nerve injury caused by thyroid surgery.

Authors:  Hedi Tian; Jun Pan; Linghui Chen; Yijun Wu
Journal:  Gland Surg       Date:  2022-01

5.  Recurrent Laryngeal Nerve Liberations and Reconstructions: A Single Institution Experience.

Authors:  Radan Dzodic; Ivan Markovic; Nada Santrac; Marko Buta; Igor Djurisic; Silvana Lukic
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

6.  Care and Management of Voice Change in Thyroid Surgery: Korean Society of Laryngology, Phoniatrics and Logopedics Clinical Practice Guideline.

Authors:  Chang Hwan Ryu; Seung Jin Lee; Jae-Gu Cho; Ik Joon Choi; Yoon Seok Choi; Yong Tae Hong; Soo Yeon Jung; Ji Won Kim; Doh Young Lee; Dong Kun Lee; GIljoon Lee; Sang Joon Lee; Young Chan Lee; Yong Sang Lee; Inn Chul Nam; Ki Nam Park; Young Min Park; Eui-Suk Sung; Hee Young Son; In Hyo Seo; Byung-Joo Lee; Jae-Yol Lim
Journal:  Clin Exp Otorhinolaryngol       Date:  2021-06-01       Impact factor: 3.372

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.